US Stock MarketDetailed Quotes

CLSD Clearside Biomedical

Watchlist
  • 1.050
  • -0.020-1.87%
Close Nov 29 13:00 ET
  • 1.080
  • +0.030+2.86%
Post 17:01 ET
79.64MMarket Cap-2333P/E (TTM)

Clearside Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Clearside Biomedical Q3 2024 Earnings Date

Currency：USDNov 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
122.86K
1.04M
+915.14K
Beat Est.
-85.70%
+20.84%
+744.86%
EPS
-0.12
-0.10
+0.02
Beat Est.
+17.14%
+33.33%
+19.48%
Analyst Rating
Strong Buy

Nov 27, 2024

Clearside Biomedical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 100.000K--
--2024/Q4-- / 294.430K--
Nov 12, 20242024/Q31.038M / 122.860K--
Aug 12, 20242024/Q290.000K / 126.500K--
May 9, 20242024/Q1230.000K / 681.250K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 100.000K--
--2024/Q4-- / 294.430K--
Nov 12, 20242024/Q31.038M / 122.860K--
Aug 12, 20242024/Q290.000K / 126.500K--
May 9, 20242024/Q1230.000K / 681.250K--

Unlock Free Earnings Estimates

Clearside Biomedical Earnings Reports

  • Clearside Biomedical | 10-Q: Q3 2024 Earnings Report

    Nov 13 11:31

  • Clearside Biomedical | 8-K: Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 13 05:16

  • Clearside Biomedical | 10-Q: Q2 2024 Earnings Report

    Aug 13 04:32

  • Clearside Biomedical | 8-K: Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update

    Aug 13 04:17

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 27, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data